isoproterenol has been researched along with chikusetsu saponin iva in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Y; Liu, C; Liu, X; Wang, J; Wang, L; Wang, T; Wu, X; Yuan, D; Zhang, C; Zheng, J; Zhou, Z | 1 |
| He, YM; Li, XX; Liu, CQ; Luo, Y; Wu, XC; Yang, MT; Yuan, CF; Zhou, ZY | 1 |
2 other study(ies) available for isoproterenol and chikusetsu saponin iva
| Article | Year |
|---|---|
Chikusetsu saponin IVa attenuates isoprenaline-induced myocardial fibrosis in mice through activation autophagy mediated by AMPK/mTOR/ULK1 signaling.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Autophagy-Related Protein-1 Homolog; Cardiomyopathies; Fibrosis; Heart; Isoproterenol; Mice, Inbred BALB C; Myocardium; Myocytes, Cardiac; Oleanolic Acid; Phosphorylation; Saponins; Serine; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
[Chikusetsu saponin Ⅳa ameliorates myocardial hypertrophy of rats through regulating expression of miR199a-5p/Atg5].
Topics: Animals; Cardiomegaly; Isoproterenol; Myocardium; Myocytes, Cardiac; Oleanolic Acid; Rats; Saponins | 2021 |